AGAdam Ezra Goldman-Yassen

Adam Ezra Goldman-Yassen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adam Ezra Goldman-Yassen has a total of 176 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neuroimaging of Pediatric Pineal Region Tumors and Other Mass Lesions

    by Adam E. Goldman-Yassen, Kartik Reddy, Manish Bajaj, Nadia Vance, Susan Palasis

    SUMMARY: Tumors of the pineal region are rare but important, accounting for approximately 4% of all pediatric intracranial tumors in the United States. The pineal region presents a wide variety of pathologies in children. Germ cell tumors are the most common pineal region tumor in children, representing more than 40% of all pineal region tumors. Pineoblastomas (World Health Organization grade 4) account for 40% of pineal parenchymal tumors. Neuroimaging, including CT and both standard and advanced MRI sequences, plays a key role in differentiating these entities by identifying characteristic features. Because management varies significantly among types, ranging from primary chemotherapy and radiation for germinomas to aggressive surgical resection for pineoblastomas, understanding these imaging characteristics and correlating them with clinical data and biomarkers are essential for appropriate patient management. Abbreviations AFP: α-fetoprotein AT/RT: atypical teratoid rhabdoid tumor β-hCG: β human chorionic gonadotropin PAT: pineal anlage tumor PLAP: placental alkaline phosphatase PPTID: pineal parenchymal tumor of intermediate differentiation PTPR: papillary tumor of the pineal region rCBV: relative CBV WHO: World Health Organization Graphical Abstract

  • Open Access

    Radiologic stewardship for pediatric intracranial infections: opportunities to reduce low-yield follow-up MRI

    by Lydia Lu, Allyson Dalby, Adam Goldman-Yassen, Jacob Lepard, Preeti Jaggi

    Among 37 previously healthy children diagnosed with focal intracranial infections, 40 routine surveillance MRIs obtained >7 days postintervention in the absence of clinical symptoms did not alter surgical or medical management. Symptom-driven repeat imaging may safely replace routine protocols, reducing unnecessary sedation, contrast exposure, and environmental impact.

  • Clinical Features, Risk Factors, and Outcomes of Pediatric Acute Encephalitis: A Retrospective Cohort Study From 2018 to 2024

    by Amy Bohling, Ashley Tippett, Morgan Morris, Anna Siaw-Anim, Adam E. Goldman-Yassen, Grace Gombolay, Christina A. Rostad

  • Open Access

    Diagnostic Errors in Pediatric Neuroradiology: Illustrative Examples and Improvement Considerations

    by Adam E. Goldman-Yassen, Neil U. Lall, Buffy Dekmar, Nadja Kadom

    SUMMARY: Diagnostic errors in pediatric neuroradiology remain underrecognized despite their potential impact on patient care. This review expands upon existing frameworks by integrating cognitive, procedural, and communication-related contributors to diagnostic error, with the goal of identifying actionable strategies for improvement. Illustrative cases were selected from a pediatric neuroradiology peer-learning database at a high-volume academic center. Errors were categorized into four domains: perceptual, interpretive, process-related, and communication-related. For each case, contributing cognitive biases and system-level failure points were analyzed, and potential mitigation strategies were identified based on peer discussion and relevant literature. Graphical Abstract

  • Pediatric Pleomorphic Xanthoastrocytomas: A Multicenter Neuroradiologic and Clinical Correlation Study

    by Karanjot Chhatwal, Thomas Hargreaves, Francesco Pacchiano, Cesar Alves, Vanessa Rameh, Adam Ezra Goldman-Yassen, Aashim Bhatia, Alok Jaju, Kristen W. Yeom, Jason Nixon, et al.

    Pleomorphic Xanthoastrocytomas (PXAs) are rare pediatric brain tumors accounting for approximately 1% of primary brain neoplasms in children and young adults. Despite recent imaging and molecular advances, gaps remain in our understanding of their diverse imaging characteristics and clinical outcomes. This study provides a large international, multi-institutional analysis of pediatric PXAs focusing on neuroimaging and clinical outcomes. We conducted a retrospective international multi-center study including 63 pediatric patients with histologically confirmed PXAs. Neuroimaging data were reviewed, and molecular analyses were recorded with emphasis on BRAF V600E mutations and CDKN2A/B deletions. Treatment modalities and clinical outcomes, including progression-free and overall survival, were analyzed using statistical survival models. 73.3% of tumors were CNS WHO grade 2 and 26.7% were CNS WHO grade 3. The median age at diagnosis was 10.7 (IQR 6.9) years. CNS WHO grade 3 tumors were significantly larger at diagnosis, with a median volume of 87,920 mm³ compared with 14,925 mm³ for grade 2 tumors (p = 0.03). BRAF V600E mutations were identified in 78% of cases and CDKN2A/B deletions in 93.5%. On MRI, PXAs typically appeared well-defined, with cortical and leptomeningeal contact (86.0% and 56.4%, respectively), frequent cysts (59.6%), and intermediate diffusivity (mean ADC 1005 × 10-6 mm2/s). CT imaging showed most tumors were isointense to gray matter (52.0%), with hydrocephalus more common in grade 3 tumors (71.4% vs. 26.3%, p = 0.07). Gross total resection was achieved in 73.7% of cases and was associated with improved progression-free survival, independent of age at diagnosis and tumor grade (HR = 0.39; 95% CI, 0.16-0.96; p = 0.041). Larger tumor volume correlated with poorer survival outcomes (HR = 3.47; 95% CI, 0.83-14.4; p = 0.087), also independent of tumor grade and age at diagnosis. Tumor recurrence occurred in 44.8% of patients at three years. The estimated three-year overall survival rate was 94.7%. Pediatric PXAs exhibit distinct neuroimaging and molecular features correlating with prognosis. Integrated evaluation of radiological and clinical features is critical to improve risk stratification and guide personalized therapeutic strategies in this rare tumor population.

  • Open Access

    The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease

    by Rowan O. Brothers, Katherine B. Turrentine, Mariam Akbar, Sydney Triplett, Hongting Zhao, Tara M. Urner, Adam Ezra Goldman-Yassen, Richard A. Jones, Jack Knight-Scott, Sarah S. Milla, et al.

    Voxelotor is an inhibitor of sickle hemoglobin polymerization that is used to treat sickle cell disease. Although voxelotor has been shown to improve anemia, the clinical benefit on the brain remains to be determined. This study quantified the cerebral hemodynamic effects of voxelotor in children with sickle cell anemia (SCA) using noninvasive diffuse optical spectroscopies. Specifically, frequency-domain near-infrared spectroscopy combined with diffuse correlation spectroscopy were used to noninvasively assess regional oxygen extraction fraction (OEF), cerebral blood volume, and an index of cerebral blood flow (CBFi). Estimates of CBFi were first validated against arterial spin–labeled magnetic resonance imaging (ASL-MRI) in 8 children with SCA aged 8 to 18 years. CBFi was significantly positively correlated with ASL-MRI–measured blood flow (R2 = 0.651; P = .015). Next, a single-center, open-label pilot study was completed in 8 children with SCA aged 4 to 17 years on voxelotor, monitored before treatment initiation and at 4, 8, and 12 weeks (NCT05018728). By 4 weeks, both OEF and CBFi significantly decreased, and these decreases persisted to 12 weeks (both P < .05). Decreases in CBFi were significantly correlated with increases in blood hemoglobin (Hb) concentration (P = .025), whereas the correlation between decreases in OEF and increases in Hb trended toward significance (P = .12). Given that previous work has shown that oxygen extraction and blood flow are elevated in pediatric SCA compared with controls, these results suggest that voxelotor may reduce cerebral hemodynamic impairments. This trial was registered at www.ClinicalTrials.gov as #NCT05018728.


  • Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity

    by Esra Sefik, Ryan M. Guest, Katrina Aberizk, Roberto Espana, Katrina Goines, Derek M. Novacek, Melissa M. Murphy, Adam E. Goldman-Yassen, Joseph F. Cubells, Opal Ousley, et al.


  • Open Access

    A Worm’s Tale or Why to Avoid the Raccoon Latrine: A Case of Baylisascaris procyonis Meningoencephalitis

    by Adam E. Goldman-Yassen, Anna Derman, Rebecca Pellett Madan, Alireza Radmanesh

    The raccoon roundworm Baylisascaris procyonis (B. procyonis) may infect humans to cause severe or fatal meningoencephalitis, as well as ocular and visceral larva migrans. Young children are at greater risk for cerebral larva migrans with severe meningoencephalitis, and early empiric therapy may improve outcomes. Familiarity with characteristic brain imaging findings may prompt earlier diagnosis, particularly in the setting of CSF eosinophilia. We report a case of a 19-month-old boy who presented with truncal ataxia and was found to have peripheral and CSF eosinophilia. MRI demonstrated symmetric, confluent T2 hyperintense signal in the cerebral and cerebellar deep white mater, which helped differentiate B. procyonis meningoencephalitis from other infectious and non-infectious causes of eosinophilic meningoencephalitis. Early recognition and treatment of B. procyonis meningoencephalitis are important for improved outcomes, and careful review of neuroimaging can play a critical role in suggesting the diagnosis.


  • Torcular Dural Sinus Malformation: Fetal and Postnatal Imaging Findings and Their Associations With Clinical Outcomes

    by Adam E. Goldman-Yassen, Anna Shifrin, David M. Mirsky, Arastoo Vossough, Daniel J. Licht, Tamara Feygin


  • Vessel wall imaging with advanced flow suppression in the characterization of intracranial aneurysms following flow diversion with Pipeline embolization device

    by Eytan Raz, Adam Goldman-Yassen, Anna Derman, Ahrya Derakhshani, John Grinstead, Seena Dehkharghani

    Background High-resolution vessel wall MRI (VWI) is increasingly used to characterize intramural disorders of the intracranial vasculature unseen by conventional arteriography. Objective To evaluate the use of VWI for surveillance of flow diverter (FD) treated aneurysms. Materials and methods Retrospective study of 28 aneurysms (in 21 patients) treated with a FD (mean 57 years; 14 female). All examinations included VWI and a contemporaneously obtained digital subtraction angiogram. Multiplanar pre- and post-gadolinium 3D, variable flip-angle T1 black-blood VWI was obtained using delay alternating nutation for tailored excitation (DANTE) at 3T. 3D time-of-flight MR angiography (MRA) was also carried out. Images were assessed for in-stent stenosis, aneurysm occlusion, presence and pattern/distribution of aneurysmal or parent vessel gadolinium enhancement. Results The VWI-MRI was performed on average at 361±259 days after the intervention. Follow-up DSA was performed at 338±254 days postintervention. Good or excellent black-blood angiographic quality was recorded in 22/28 (79%) pre-contrast and 21/28 (75%) post-contrast VWI, with no cases excluded for image quality. Aneurysm enhancement was noted in 24/28 (85.7%) aneurysms, including in 79% of angiographically occluded aneurysms and 100% of angiographically non-occluded aneurysms. Enhancement of the stented parent-vessel wall occurred significantly more often when aneurysm enhancement was present (92% vs 33%, p=0.049). Conclusion Advanced VWI produces excellent depiction of FD-treated aneurysms, with robust evaluation of the parent vessel and aneurysm wall to an extent not achievable with conventional MRI/MRA. Gadolinium enhancement may, however, continue even after enduring catheter angiographic occlusion, confounding interpretation, and requiring cognizance of this potentially prolonged effect in such patients.